《美股業績》AMD上季收入遜預期 AI晶片銷售按季增21% 盤後跌逾4%
AMD(AMD.US)公布,第三季調整後盈利為70美仙,每股收益18美仙,調整後每股收益70美仙,較預期的68美仙高,該股於市後交易時段跌逾4%。
期內,收入增4%至58億美元,高於預期的57億美元。於電腦晶片推動下,AMD包括電腦處理器銷售額的客戶部門收入增42%至15億美元。伺服器處理器和人工智能晶片在內的資料中心銷售額為16億美元,與去年同期持平,但按季增21%。
AMD預期,第四季銷售額介乎58億美元至64億美元,符合分析師預期的63.7億美元,預計調整後毛利率約為51.5%,而第三季為51%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.